Takenori Yamaguchi - Concepedia

Author

Takenori Yamaguchi

National Cerebral and Cardiovascular Center ORCID

Also Known As

Hirofumi Nakayama, Kazunori Toyoda, M.J. Rosas, Study sponsor, T YAMAGUCHI, T Yamaguchi, T. Yamaguchi, TAKENORI YAMAGUCHI, TAKENORI YAMAGUCHI M.D., Takenori YAMAGUCHI

445

Publications

18.4K

Citations

H-Index

121

Concepts

All Affiliations

National Cerebral and Cardiovascular Center National Kyushu Medical Center Nippon Medical School Kyushu University Osaka National Hospital

About

Takenori Yamaguchi is an author at National Cerebral and Cardiovascular Center specializing in medicine, neurology, and stroke.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	65	9.8K
2	Public Health	25	35	7.6K
3	Health Sciences	10	11	656
4	Engineering	2	2	35
5	Business	1	1	178

Takenori Yamaguchi

145

Publications

16.7K

Citations

H-Index

Page 1

	Year	Citations
Vascular dementia Gustavo C. Román, T. K. Tatemichi, Timo Erkinjuntti, Neurology Cerebrovascular DiseaseNeurovascular DiseaseStroke RehabilitationAlzheimer's DiseaseStroke	1993	4.9K
The Cognitive Abilities Screening Instrument (CASI): A Practical Test for Cross-Cultural Epidemiological Studies of Dementia Evelyn L. Teng, Kazuo Hasegawa, Akira Homma, International Psychogeriatrics NeuropsychologyPractical TestCognitive RehabilitationSocial SciencesPsychology	1994	898
Ebselen in Acute Ischemic Stroke Takenori Yamaguchi, Keiji Sano, Kintomo Takakura, Stroke	1998	605
Enlargement of Spontaneous Intracerebral Hemorrhage Seiji Kazui, Hiroaki Naritomi, Haruko Yamamoto, Stroke	1996	566
Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset Takenori Yamaguchi, Etsuro Mori, Kazuo Minematsu, Stroke	2006	508
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial Yukito Shinohara, Yasuo Katayama, Shinichiro Uchiyama, The Lancet Neurology ThrombosisIschemic StrokeCardiovascular DiseaseMedicineSecondary Stroke	2010	483
Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction Fumio Gotoh, Hideo Tohgi, Shunsaku Hirai, Journal of Stroke and Cerebrovascular Diseases ThrombosisIschemic StrokeCardiovascular DiseaseMedicineSecondary Prevention	2000	345
Hemorrhagic transformation in cerebral embolism. Yasushi Okada, Takenori Yamaguchi, Kazuo Minematsu, Stroke Cerebrovascular DiseaseBlood PressureNeurovascular DiseaseHemorrhagic InfarctionThrombosis	1989	305
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation Takenori Yamaguchi Stroke	2000	287
Low-Dose Aspirin for Prevention of Stroke in Low-Risk Patients With Atrial Fibrillation Hiroshi Sato, Kinji Ishikawa, Akira Kitabatake, Stroke	2005	282

Page 1